Dr Reddy's Laboratories - Stock Price History | RDY
Historical daily share price chart and data for Dr Reddy's Laboratories since 2019 adjusted for splits. The latest closing stock price for Dr Reddy's Laboratories as of December 10, 2019 is 41.08.
- The all-time high Dr Reddy's Laboratories stock closing price was 67.79 on October 19, 2015.
- The Dr Reddy's Laboratories 52-week high stock price is 42.82, which is 4.2% above the current share price.
- The Dr Reddy's Laboratories 52-week low stock price is 34.67, which is 15.6% below the current share price.
- The average Dr Reddy's Laboratories stock price for the last 52 weeks is 38.30.
Dr Reddy's Laboratories Historical Annual Stock Price Data |
Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
2018 |
33.7714 |
38.0900 |
39.5400 |
28.4900 |
37.7000 |
0.37% |
2017 |
38.9331 |
45.4400 |
46.7000 |
30.1100 |
37.5600 |
-17.05% |
2016 |
46.2125 |
45.6500 |
54.4500 |
41.2200 |
45.2800 |
-2.18% |
2015 |
56.3194 |
50.1100 |
67.7900 |
43.5500 |
46.2900 |
-8.25% |
2014 |
46.3439 |
40.3000 |
58.3900 |
38.6700 |
50.4500 |
22.96% |
2013 |
36.7077 |
34.1900 |
41.1900 |
32.0000 |
41.0300 |
23.25% |
2012 |
31.7270 |
30.1500 |
35.0600 |
27.4100 |
33.2900 |
13.12% |
2011 |
33.8428 |
37.3300 |
39.2400 |
29.0700 |
29.4300 |
-20.37% |
2010 |
30.7362 |
24.8800 |
41.7600 |
23.3400 |
36.9600 |
52.66% |
2009 |
15.3837 |
10.2100 |
26.1300 |
7.4100 |
24.2100 |
147.04% |
2008 |
13.2925 |
18.2800 |
18.2800 |
7.5300 |
9.8000 |
-46.04% |
2007 |
16.3241 |
18.1000 |
18.5800 |
14.5100 |
18.1600 |
-0.22% |
2006 |
15.2735 |
10.9000 |
19.0600 |
10.9000 |
18.2000 |
68.52% |
2005 |
9.0628 |
9.8600 |
10.9250 |
7.5600 |
10.8000 |
8.93% |
2004 |
10.2201 |
16.1000 |
16.5050 |
7.5400 |
9.9150 |
-37.35% |
2003 |
11.4112 |
9.8300 |
16.0700 |
8.8500 |
15.8250 |
63.74% |
2002 |
9.5612 |
9.6000 |
11.9000 |
6.8800 |
9.6650 |
2.01% |
2001 |
9.4095 |
5.0500 |
12.7000 |
5.0500 |
9.4750 |
0.00% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$6.698B |
$2.225B |
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
|